Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical […]
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical […]
Wildfires in the West have devastated a number of marijuana farms in Oregon, Washington state and California, while an early freeze hit […]
Canadian cannabis producer Cronos Group reported $165,000 in net revenue from customers outside Canada and the United States in its latest quarter. […]